Navigation Links
BiphedAdrene™, Complex Phenylethylamine Provisional Plus Aggressive Thermogenic Compound, Leads Super-Powerful "Diet Pill" Comeback
Date:1/3/2012

SALT LAKE CITY, Jan. 3, 2012 /PRNewswire/ -- When the FDA removed Fen-Phen from the U.S. market in 1997 and Ephedra in 2004, U.S. consumers believed that powerful diet pills had become a thing of the past. Instead a huge, "underground," multi-billion-dollar market for amphetamine-like fat burners sprung up almost immediately, and it wasn't long before these types of products started quietly showing up in gym bags and medicine cabinets.

Demand for these "go-fast" pills has risen to such levels that local retailers like Wal-Mart, Walgreen's, and GNC are now carrying the high-quality, extremely effective versions of them, and leading the pack is Generix Labs™ newest product, BiphedAdrene™.

BiphedAdrene is a two-part system comprised of a unique "Complex Phenylethylamine Provisional" (for powerful appetite control, mood-elevation, and energy) and an aggressive thermogenic compound (for fat burning and stamina). Clearly created for consumers seeking successful weight loss and body fat reduction, this product is also attracting a new clientele: college students, fitness enthusiasts... even overstressed, exhausted homemakers who are all looking for something that can give them increased energy and a boost in stamina.

"Super pills" like BiphedAdrene are becoming hugely popular, but they're not for everyone. Because of the nature of their highly effective compounds, they were designed specifically for the significantly overweight... not those who just need to lose 5 or 6 "vanity pounds." And they should only be taken by those who are in overall good health, so check with your doctor before trying one of these super-powerful "diet pills."

If you want to try BiphedAdrene, check your local GNC or Wal-Mart. You can also order it directly from Generix Labs by visiting www.BiPhed.com.

And here's an inside tip: If you order from Generix Labs, make sure to use promo code INSTOCK. Why? Demand for BiphedAdrene has been so high the company has had difficulty keeping it in stock. As a way to apologize to customers who've been waiting to get their hands on a box, Generix is offering a $25 discount when you use that code. (Note: The INSTOCK promo code was still valid as of January 2, 2012.)

 

 

 


'/>"/>
SOURCE BiphedAdrene
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
2. Franklin & Seidelmann Publishes Complex Podiatry MRI Study
3. Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders
4. SCAI: CARDia Data Find Diabetic Patients With Complex Heart Disease Can Safely Choose PCI
5. SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease
6. SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery
7. Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized Moderate Complexity by FDA
8. SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease
9. Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients
10. SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease
11. CardioVascularCS.Org, a division of EndoVascular Forum, Inc., Partners with Complex Interventional Cardiovascular Therapy (CICT) to Extend Electronic Medical Care Advancement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (United States, China, Japan, Brazil, United Kingdom, Germany, France, ... Surgical Procedure Volumes: ... provides surgical procedure volume data in a geographic context. ... analysis of growth drivers and inhibitors, including world population ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
Breaking Medicine News(10 mins):